BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38280459)

  • 21. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
    Fagan AM; Holtzman DM
    Microsc Res Tech; 2000 Aug; 50(4):297-304. PubMed ID: 10936884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol.
    Wang H; Kulas JA; Wang C; Holtzman DM; Ferris HA; Hansen SB
    Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34385305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
    Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
    PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?
    Kanekiyo T; Xu H; Bu G
    Neuron; 2014 Feb; 81(4):740-54. PubMed ID: 24559670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron Regulates Apolipoprotein E Expression and Secretion in Neurons and Astrocytes.
    Xu H; Perreau VM; Dent KA; Bush AI; Finkelstein DI; Adlard PA
    J Alzheimers Dis; 2016; 51(2):471-87. PubMed ID: 26890748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
    Mulder SD; Veerhuis R; Blankenstein MA; Nielsen HM
    Exp Neurol; 2012 Jan; 233(1):373-9. PubMed ID: 22101005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pro-neurotrophin receptor sortilin is a major neuronal apolipoprotein E receptor for catabolism of amyloid-β peptide in the brain.
    Carlo AS; Gustafsen C; Mastrobuoni G; Nielsen MS; Burgert T; Hartl D; Rohe M; Nykjaer A; Herz J; Heeren J; Kempa S; Petersen CM; Willnow TE
    J Neurosci; 2013 Jan; 33(1):358-70. PubMed ID: 23283348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro.
    Mulder SD; Nielsen HM; Blankenstein MA; Eikelenboom P; Veerhuis R
    Glia; 2014 Apr; 62(4):493-503. PubMed ID: 24446231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
    Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Aβ uptake and degradation by astrocytes.
    Basak JM; Verghese PB; Yoon H; Kim J; Holtzman DM
    J Biol Chem; 2012 Apr; 287(17):13959-71. PubMed ID: 22383525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of memory deficits and amyloid-β clearance in aged APP23 mice treated with a combination of anti-amyloid-β antibody and LXR agonist.
    Fitz NF; Castranio EL; Carter AY; Kodali R; Lefterov I; Koldamova R
    J Alzheimers Dis; 2014; 41(2):535-49. PubMed ID: 24643138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model.
    Huynh TV; Wang C; Tran AC; Tabor GT; Mahan TE; Francis CM; Finn MB; Spellman R; Manis M; Tanzi RE; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2019 Oct; 14(1):37. PubMed ID: 31623648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain.
    Kim J; Yoon H; Horie T; Burchett JM; Restivo JL; Rotllan N; Ramírez CM; Verghese PB; Ihara M; Hoe HS; Esau C; Fernández-Hernando C; Holtzman DM; Cirrito JR; Ono K; Kim J
    J Neurosci; 2015 Nov; 35(44):14717-26. PubMed ID: 26538644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
    Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T
    Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA.
    Yajima R; Tokutake T; Koyama A; Kasuga K; Tezuka T; Nishizawa M; Ikeuchi T
    Biochem Biophys Res Commun; 2015 Jan; 456(1):482-8. PubMed ID: 25482438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
    Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
    J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.
    Lv J; Ma S; Zhang X; Zheng L; Ma Y; Zhao X; Lai W; Shen H; Wang Q; Ji J
    J Proteomics; 2014 Oct; 110():45-58. PubMed ID: 25108202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Sirt2 Decreases ApoE Secretion in Astrocytes and Microglial Cells.
    Chen Y; Zhou C; Abdelhamid M; Jung CG; Michikawa M
    J Biochem; 2023 Oct; 174(5):409-420. PubMed ID: 37488092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.